Search alternatives:
marked decrease » marked increase (Expand Search)
a market » _ market (Expand Search), a marker (Expand Search)
marked decrease » marked increase (Expand Search)
a market » _ market (Expand Search), a marker (Expand Search)
-
1
Graphical presentation of First-order release of aspirin from CPB and marketed brands.
Published 2024“…<p>F8 represents the release profile of aspirin from the Check Point Batch (CPB); STD<sub>1A</sub>- represents the % release of aspirin from 1<sup>st</sup> marketed brands; STD<sub>2A</sub>- illustrates the rate of drug release from 2<sup>nd</sup> brand and STD<sub>3A</sub>- from the 3<sup>rd</sup> marketed brand over time.…”
-
2
-
3
-
4
-
5
-
6
Number and classification of released policies.
Published 2024“…Finally, in the subject dimension of policy release, the synergy of relevant subjects is constantly improving, but there is also a phenomenon of over-concentration in the synergistic departments.…”
-
7
-
8
Static release and osmolality test.
Published 2025“…The currently marketed form I and the self-prepared form II were characterized by XRD, DSC, FT-IR, and SEM, confirming that form II is a new polymorphic form of TOC. …”
-
9
-
10
‘BRS Serenata’: a peach for fresh market
Published 2021“…The ‘BRS Serenata’ cultivar was released to fulfill a gap of white flesh peach between the seasons of ‘BRS Kampai’ and ‘BRS Fascínio’.…”
-
11
-
12
-
13
-
14
-
15
-
16
‘BRS Cainguá’, a blackberry fresh-market cultivar
Published 2020“…The fruits of the newly released cultivar BRS Cainguá taste better and have a very attractive shape.…”
-
17
Press release: A tool for public relations
Published 2022“…Press releases are amongst the most popular form of communication utilised by corporate institutions such as banking establishments as a tool for the maintenance of sound public relations. …”
-
18
-
19
-
20
Population pharmacokinetics of immediate-release and modified-release paracetamol and its major metabolites in a supratherapeutic dosing study
Published 2021“…<p>Overdose with paracetamol modified-release (MR) formulation, a bilayer tablet containing 69% slow-release component, has been increasing since its introduction to the market. …”